promise to drain the swamp. looks like we got a lot of rich people going to this administration. they ve given a lot of money to politicians. do they reflect america? do they reflect the people who voted for donald trump? i don t think so. the concern is we have a director of education who knows much about the need for public schools. and whether she s just going to focus on for-profit education. so they need to look at her financial conflicts of interest going forward and same with all the other cabinet nominees. a billionairer who has been nominated for secretary of commerce. he s go having to conflicts of interest going to the had job and we have congressman price
interchangeability with the reference project. i was concerned that in 2017, having gone through two full presidential terms, just yesterday we finally got a draft of the fda s interchangeability policy. i ll ask that question, since my time has expired, in writing. thank you. thank you, senator enzi. senator sanders. thank you, mr. chairman. congressman price, thanks for being here and for the conversation we had the other day. thank you. congressman, on may 7, 2015 let me begin by saying all of us know that we have come through a very unusual election process. president-elect trump received almost 3 million votes less than secretary clinton. but he won the electoral college. he s going to be inaugurated this week. he won a number of states by rather slim margins.
there was a bill subsequently called the stock act but it had to prove insider trading, it didn t actually ban members of congress dealing in stocks that they have oversight over. manu raju talked about this medical device that was roughly about $2,000 which is how much much money tom price might have made. it was some oversight his committee had, there s a difference between what s legal and what s ethical and tom price said he did nothing illegal. as they continue to try to drain the swamp this will be an issue to voters not to just congressman price but possibly
okay, we have taken care of it because now we have an agency that s addressed. we need better metrics and better accountability for what s going on. i m sure you talked at some length about rare diseases. i would love to perhaps submit some questions for the record to get your insight and perspective on how e we tack it l so many of those diseases moving forward. look forward to that it, senator. thank you. thank you, senator scott. senator murray? thank you, mr. chairman. congressman price, i did want to clarify your response to one of my previous questions. you admitted to me in our meeting that you in your own words, talked with congressman collins about innate. this inspired you to, in your own words, study the company and purchase its stock.
replacement, but that was a principle articulated by congressman price. sanjay gupta, you are a physician just like dr. price is a physician. in fact, you worked at the same hospital where he was an orthopedic surgeon. what was your immediate impression listening to the exchanges not just from the republicans, but the democrats as well? well, you know, tom price is somebody who has put out a plan, as you pointed out, almost every year since the affordable care act was put into place. we didn t hear a lot of those specific details, though. i thought that was a little bit surprising. there were a couple of areas that i think they drilled down on. one was very interesting. may go under the radar a little bit, but, again, with senator sanders saying specifically will you allow an organization like medicare to negotiate prices for drugs? it s a huge point. it s a huge point because right now they cannot negotiate prices for drugs. they are some of the biggest cost to our health care sys